Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q6)Feb 28, 2025 | (FY)Aug 31, 2024 | (Q6)Feb 29, 2024 | (FY)Aug 31, 2023 | (Q6)Feb 28, 2023 | (FY)Aug 31, 2022 | (Q6)Feb 28, 2022 | (FY)Aug 31, 2021 | (Q6)Feb 28, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -22.09%84.47M | -23.46%51.77M | -21.01%108.42M | -15.26%67.64M | 33.02%137.26M | 23.00%79.82M | -20.48%103.19M | -25.05%64.89M | -9.09%129.76M | --86.58M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 40.02%-7.96M | 27.48%-5.3M | 29.90%-13.27M | -9.47%-7.31M | -10.68%-18.93M | 16.10%-6.68M | -40.14%-17.1M | -139.92%-7.96M | -22.33%-12.2M | ---3.32M |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | --4M | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | --4M | ---- | ---- | ---- |
| Revaluation surplus: | 64.03%-300K | ---- | -7,481.82%-834K | ---- | -100.40%-11K | -99.64%25K | 182.17%2.78M | 426.58%6.92M | -104.04%-3.38M | ---2.12M |
| -Other fair value changes | 64.03%-300K | ---- | -7,481.82%-834K | ---- | -100.40%-11K | -99.64%25K | 182.17%2.78M | 426.58%6.92M | -104.04%-3.38M | ---2.12M |
| Asset sale loss (gain): | 50.00%27K | -88.89%2K | 1,700.00%18K | --18K | -99.82%1K | ---- | 220.00%560K | 492.68%486K | 153.62%175K | --82K |
| -Loss (gain) on sale of property, machinery and equipment | 50.00%27K | -88.89%2K | 1,700.00%18K | --18K | -99.82%1K | ---- | 220.00%560K | 492.68%486K | 153.62%175K | --82K |
| Depreciation and amortization: | -6.53%43.4M | -8.93%21.12M | 7.62%46.43M | 12.21%23.19M | 11.91%43.15M | 9.19%20.66M | -0.59%38.56M | 5.06%18.92M | -3.46%38.79M | --18.01M |
| -Amortization of intangible assets | -2.83%2.13M | -5.13%1.05M | -18.42%2.19M | -23.64%1.11M | 40.17%2.69M | 58.67%1.46M | 32.39%1.92M | 15.06%917K | 9.04%1.45M | --797K |
| Financial expense | -52.45%68K | 26.09%87K | 22.22%143K | 165.38%69K | 134.00%117K | --26K | --50K | ---- | ---- | ---- |
| Special items | ---- | ---- | ---- | ---- | -94.07%202K | ---- | --3.41M | ---- | ---- | ---- |
| Operating profit before the change of operating capital | -15.05%119.71M | -19.05%67.67M | -12.90%140.91M | -10.93%83.59M | 19.46%161.79M | 12.72%93.85M | -11.56%135.44M | -16.10%83.26M | -10.63%153.14M | --99.23M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -4.92%-64K | -69.23%-22K | 66.11%-61K | -172.22%-13K | -122.22%-180K | -76.32%18K | 58.88%-81K | 261.90%76K | ---197K |
| Accounts payable increase (decrease) | -135.31%-244K | -73.46%-19.02M | -88.63%691K | -244.36%-10.96M | 111.67%6.08M | 117.02%7.6M | -556.37%-52.09M | -12.57%-44.62M | 182.37%11.41M | ---39.64M |
| prepayments (increase)decrease | -91.83%5.26M | -1,339.13%-14.64M | 290.40%64.31M | 90.79%-1.02M | 18.86%-33.78M | 46.82%-11.04M | -197.66%-41.63M | -254.10%-20.76M | -179.14%-13.98M | --13.47M |
| Special items for working capital changes | ---- | 43.42%-5.28M | ---- | 86.97%-9.33M | ---- | -9.75%-71.61M | -92.49%15.04M | -151.26%-65.25M | 199.62%200.21M | --127.3M |
| Adjustment items for working capital changes | ---- | 110.00%1K | ---- | ---10K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | -39.43%124.72M | -53.91%28.67M | 53.56%205.89M | 234.21%62.21M | 136.13%134.08M | 139.23%18.62M | -83.82%56.78M | -123.70%-47.45M | 1,460.63%350.85M | --200.17M |
| Interest received - operating | ---- | -31.75%4.88M | ---- | 61.28%7.14M | ---- | 34.38%4.43M | 1,511.56%8.78M | 1,531.68%3.3M | 57.06%545K | --202K |
| Special items of business | -32.97%-9.35M | ---- | 87.04%-7.03M | ---- | ---54.27M | ---- | ---- | ---- | ---- | ---- |
| Adjustment items of business operations | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | -41.99%115.36M | -51.63%33.55M | 149.15%198.86M | 200.98%69.36M | 21.73%79.81M | 152.19%23.04M | -81.34%65.57M | -122.04%-44.15M | 1,481.34%351.4M | --200.37M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -44.76%7.73M | 627.12%429K | -25.68%13.98M | --59K | 110.84%18.82M | ---- | -24.24%8.92M | 34.91%4.21M | 2.99%11.78M | --3.12M |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | --21K | ---- | ---- | ---- |
| Purchase of fixed assets | -53.07%-416.41M | -123.28%-190.85M | -66.85%-272.04M | -78.96%-85.47M | -47.82%-163.05M | -173.05%-47.76M | -15.20%-110.3M | 13.41%-17.49M | -179.25%-95.75M | ---20.2M |
| Purchase of intangible assets | -1,114.29%-850K | ---- | 97.06%-70K | 96.68%-70K | 66.61%-2.38M | 63.74%-2.11M | -776.75%-7.13M | ---5.82M | 82.73%-813K | ---- |
| Recovery of cash from investments | 175.54%220.43M | 213.98%70.13M | -27.93%80M | 36.77%22.34M | -73.41%111M | -98.39%16.33M | -81.03%417.41M | 23.34%1.01B | 50.68%2.2B | --821.66M |
| Cash on investment | -7.14%-150M | ---- | -15.70%-140M | ---50M | ---121M | ---- | ---- | 39.05%-640M | -52.58%-2.35B | ---1.05B |
| Other items in the investment business | 34.13%4.19M | --3.62M | -25.64%3.12M | ---- | -28.60%4.2M | -33.19%3.93M | -9.78%5.88M | 32.85%5.88M | 1,202.80%6.51M | --4.42M |
| Adjustment items of investment business | ---- | ---- | ---- | --5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -6.32%-334.92M | -7.88%-116.67M | -106.67%-315M | -265.18%-108.15M | -148.42%-152.42M | -108.22%-29.62M | 238.02%314.8M | 249.47%360.24M | -116.05%-228.09M | ---241.01M |
| Net cash before financing | -89.04%-219.56M | -114.28%-83.13M | -59.97%-116.15M | -490.29%-38.79M | -119.09%-72.6M | -102.08%-6.57M | 208.47%380.37M | 877.80%316.08M | 194.12%123.31M | ---40.64M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --33.95M | -3,600.00%-18.5M | ---- | -102.50%-500K | --20M | --20M | ---- | ---- | ---- | ---- |
| Refund | -1,750.00%-18.5M | ---- | -100.00%-1M | ---- | ---500K | ---- | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---70K | --401.14M | ---- |
| Interest paid - financing | 64.61%-212K | -27.54%-88K | -70.66%-599K | -165.38%-69K | -602.00%-351K | 0.00%-26K | ---50K | ---26K | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | -619.90%-123.13M | ---- | ---17.1M | ---- |
| Other items of the financing business | -70.12%144K | ---- | 84.67%482K | ---- | --261K | ---- | ---- | ---27.83M | ---- | ---- |
| Net cash from financing operations | 1,275.43%14.49M | -3,197.36%-18.76M | -106.49%-1.23M | -102.91%-569K | 115.31%19M | 169.10%19.57M | -132.31%-124.08M | ---28.31M | 4,518.05%384.04M | ---- |
| Effect of rate | 99.82%-1K | 230.81%1.68M | -108.10%-569K | -178.41%-1.28M | -25.52%7.03M | 163.45%1.64M | 629.33%9.44M | ---2.58M | ---1.78M | ---- |
| Net Cash | -74.71%-205.07M | -158.84%-101.89M | -118.98%-117.38M | -402.93%-39.36M | -120.91%-53.6M | -95.48%12.99M | -49.48%256.29M | 808.13%287.77M | 513.49%507.34M | ---40.64M |
| Begining period cash | -14.49%695.9M | -14.49%695.9M | -5.41%813.84M | -5.41%813.84M | 44.68%860.42M | 44.68%860.42M | 567.24%594.69M | 567.24%594.69M | -57.92%89.13M | --89.13M |
| Cash at the end | -29.47%490.83M | -22.96%595.69M | -14.49%695.9M | -11.64%773.2M | -5.41%813.84M | -0.55%875.05M | 44.68%860.42M | 1,714.59%879.88M | 567.24%594.69M | --48.49M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.